It’s a branded drug with the active ingredient dapagliflozin. Farxiga comes in the strengths of 5 milligrams (mg) and 10 mg. Your dosage will depend on factors like what condition is being treated.

Dosage for reducing risks from heart failure Farxiga is approved to reduce certain risks from heart failure. The recommended dosage for this use is 10 mg once per day. This is the maximum dosage ...

Type 2 diabetes is the most common form of diabetes. It can be diagnosed at any age and increases your risk of several other health problems. Farxiga (far-see-guh) is just one of the many ...

Is the risk of side effects lower with the 5-mg dose of Farxiga than with the 10-mg dose? It depends. Generally, taking a higher dose of medication will increase your risk of side effects.

In a pool of 12 placebo-controlled studies, the most common adverse reactions (≥5%) associated with FARXIGA 5 mg, 10 mg, and placebo respectively were female genital mycotic infections (8.4% vs ...

The most common adverse reaction reported in the trial was headache (14.8% with dapagliflozin vs 5.3% with placebo). Farxiga is supplied in 5mg and 10mg strength tablets.

Patients were randomized to receive either Farxiga 10mg once daily or placebo. The primary composite outcome was the time to first occurrence of CV death or worsening HF (hospitalization or an ...

The overall incidence of adverse events in patients treated with Forxiga 10 mg was similar to placebo. Few adverse events led to discontinuation of treatment and incidences were balanced across ...

Glenmark gave no potential launch date for the generic approved by the FDA at 5 mg and 10 mg strengths. AZ did not mention the impact of generic competition for Farxiga in the US in its full year ...

It involved over 4,300 patients for assessing the efficacy of Farxiga 10mg in patients with CKD Stages 2-4 and elevated urinary albumin excretion, with and without T2D. The patients are ...

It will allow patients and clinicians participating in registries to join the trial and integrate it within their routine clinical practice, and will enrol around 6,400 patients who will receive ...